Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Na_3Zr_2Si_2PO_(12)X射线衍射数据的测定
Na_3AlF_6-AlF_3-LiF-MgF_2-Al_2O_3-Nd_2O_3-CuO熔盐体系电导率的研究
Na_3PO_4对模拟汽车冷却液中AM60镁合金的缓蚀作用
Na_3PO_4和Cu、Ti对Al-18Si合金切削性能的影响
Na_3V_2(PO_4)_3/C复合材料的制备及电化学性能研究
Na_3AlF_6-AlF_3-Al_2O_3-CaF_2-KCl系铝电解质初晶温度的研究
Na_3PO_4·12H_2O选择性催化脱去芳香性叔丁基二甲基硅醚
Na_3Ba_2B_6O_(12)F晶体的生长及电子结构计算
Na_3ZrF_7:Er/Yb纳米颗粒的合成及荧光性能研究
Na_3AlF_6-AlF_3-LiF-MgF_2-La_2O_3-Al_2O_3熔盐体系密度的研究
Na_3B_3H_n团簇的结构与电子特性
Na_3AlF_6-AlF_3-LiF-MgF_2-Al_2O_3-Sm_2O_3熔盐体系表面张力的研究
Na_3AlF_6-K_3AlF_6-AlF_3熔盐体系的物理化学性质研究进展
Na_4Ca_3(AlO_2)_(10)∶Eu~(2+),Mn~(2+)荧光粉的发光特性
Na_4-CyDTA空间位阻的动态核磁共振研究
Na_4Ca_4Al_6Si_9O_(24)∶Ce~(3+),Tb~(3+)荧光粉合成及其能量传递研究(英文)
Na_5P_3O_(10)的加入量对ZrH_(1.8)表面微弧氧化膜的影响
Na_5[B_2P_3O_(13)]晶体双晶结构的研究
Na_5,Na_6和Na_7团簇光学吸收谱的理论研究
Na_5P_3O_(10)体系氢化锆表面微弧氧化陶瓷层组织与阻氢性能的研究
Na_5[Ce(ZrMo_(11)O_(39))]·xH_2O杂多酸盐的光催化降解性能
Na_6V_(10)O_(28)·12H_2O的合成与结构
Na_6团簇2D和3D结构的竞争
Na_6PMo_(11)FeO_(40)对小鼠黑色素瘤B16细胞内黑色素合成抑制及抑菌活性研究
Na_n(5≤n≤10)小团簇相变
Na_v1.2IQ及其癫痫突变体的表达纯化和活性鉴定
Na_xM_yFe(CN)_6(M=Fe,Co,Ni):一类新颖的钠离子电池正极材料
Na_xCo_2O_4基复合材料的制备及其热电性能
Na_xCoO_2热电性质的第一性原理研究(英文)
Na_xSr_(1-2x)MoO_4∶Eu_x~(3+)的制备及其发光性能的研究
Naa10 in development and disease
Naa10p表达对舌鳞癌Tca8113细胞平阳霉素敏感性的影响
Naa10p和CEA在唾液中联合检测对口腔鳞癌的诊断价值
Naa50/San-dependent N-terminal acetylation of Scc1 is potentially important for sister chromatid cohesion
纳爱斯:流变而生意,柔进而上行
Naamidines H and I, cytotoxic imidazole alkaloids from the Indonesian marine sponge Leucetta chagosensis
Naaman sends thanks for Distinguished Educator Award
那安壮语亲属称谓词的一些特殊用法
那安壮语第一人称单数tan~6的用法及其来源
那安侬话“部分-整体”式合成名词及其“数+量”结构的意义
Naasia aerilata gen. nov., sp nov., a member of the family Microbacteriaceae isolated from air
nab (R)-Paclitaxel in Combination with Carboplatin as First-line Therapy in Patients (pts) with Advanced Non-small Cell Lung Cancer (NSCLC): Analysis of Pt Characteristics and Clinical Treatment Patterns by Region
nab-Paclitaxel weekly or every 3 weeks compared to standard docetaxel as first-line therapy in patients with metastatic breast cancer: an economic analysis of a prospective randomized trial
nab-Paclitaxel for first-line treatment of patients with metastatic breast cancer and poor prognostic factors: a retrospective analysis
Nab-Paclitaxel Is an Active Drug in Preclinical Model of Pediatric Solid Tumors
Nab-paclitaxel: potential for the treatment of advanced pancreatic cancer
Nab-Paclitaxel for Metastatic Pancreatic Cancer: Clinical Outcomes and Potential Mechanisms of Action
nab-paclitaxel for the management of patients with advanced non-small-cell lung cancer
Nab-Paclitaxel/Bevacizumab/Carboplatin Chemotherapy in First-Line Triple Negative Metastatic Breast Cancer
Nab-Paclitaxel Plus S-1 Shows Increased Antitumor Activity in Patient-Derived Pancreatic Cancer Xenograft Mouse Models
nab-Paclitaxel in Combination With Weekly Carboplatin With Concurrent Radiotherapy in Stage III Non-Small Cell Lung Cancer